Navigation Links
Talecris Biotherapeutics Announces First Quarter 2011 Results
Date:4/27/2011

nhanced by a quantified presentation of the impact of the 2011 Grifols merger-related expenses and interest expense on PCA judgment.  The impacts of these expenses on net income and diluted earnings per share are illustrated in the table below.

The adjusted net income and diluted earnings per share amounts in the table below are non-GAAP financial measures and should not be considered a substitute for any performance measure determined in accordance with U.S. GAAP.  Additional information regarding the use of these non-GAAP financial measures is included in Talecris' Form 10-Q filed with the SEC on April 27, 2011, which is available on SEC's website at www.sec.gov and Talecris' website at http://ir.talecris.com.Diluted EarningsPre-TaxIncome TaxPer(in thousands, except per share amounts)AmountBenefitNet IncomeCommon ShareThree Months Ended March 31, 2011U.S. GAAP$
83,196$
(27,739)$
55,457$
.43Grifols merger-related expenses4,118(1,552)2,5660.02Interest on PCA judgment740(289)451-Excluding specific items$
88,054$
(29,580)$
58,474$
.45Three Months Ended March 31, 2010U.S. GAAP$
8,603$
(23,264)$
45,339$
.35EBITDA, Adjusted EBITDA, and Consolidated Cash FlowTalecris believes that a meaningful analysis of its operating performance is enhanced by the use of EBITDA, adjusted EBITDA as defined in Talecris' revolving credit facility and Consolidated Cash Flow as defined in its 7.75% Notes.

EBITDA, adjusted EBITDA, and Consolidated Cash Flow are financial measures that are not defined by accounting principles generally accepted in the U.S. (U.S. GAAP).  A non-GAAP financial measure is a numerical measure of a company's financial performance that (i) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in a comparable measure calculated and presented in accordance wi
'/>"/>

SOURCE Talecris Biotherapeutics Holdings Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
2. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
3. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
4. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
5. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
6. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
7. Talecris Added to NASDAQ Biotechnology Index
8. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
9. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
10. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
11. Talecris Biotherapeutics Announces Premerger HSR Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014   Synthetic Biologics, ... developing novel anti-infective biologic and drug programs targeting ... announced today that its novel C. difficile ... 54 th Interscience Conference on Antimicrobial Agents ... Washington D.C. Synthetic Biologics, ...
(Date:8/18/2014)... -- A new therapy developed by researchers at ... of Medicine and Columbia University Medical Center (CUMC) ... cardiovascular disease treatment. , The researchers demonstrated ... therapy could selectively inhibit blood vessel re-narrowing and ... using a balloon catheter to open narrowed or ...
(Date:8/18/2014)... and data storage may someday run on ... to read and write digital information, outperforming ... But ferroelectrics must first overcome a few ... of "forgetting" stored data. , Now, ... Brookhaven National Laboratory have discovered nanoscale asymmetries ...
(Date:8/18/2014)... 2014 TNI BioTech, Inc. (OTC-BB: TNIB) ("we" ... and marketing of innovative therapies for autoimmune diseases in ... a second notice of TNI BioTech,s annual meeting of ... Noreen Griffin , founder and CEO of TNI ... participation in the Annual Meeting. On behalf of our ...
Breaking Biology Technology:Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... and Company 29th Annual Health Care Conference on Tuesday, ... parties may access a live webcast of the presentation ... is recommended that listeners log on 15 minutes early ...
... Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting ... on Tuesday, March 17, 2009 at 8:00 a.m. ... Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will ... will be webcast, and a recording will be made available ...
... Research Centers in Germany and Portugal Indicates ... Wash., March 10 BioLife Solutions, Inc. ... and marketer of proprietary cGMP hypothermic storage ... and organs, today announced that an independent ...
Cached Biology Technology:Improved Cryopreservation Outcomes in Potential $100B Tissue Engineering Market Enabled by BioLife Solutions CryoStor(TM) 2Improved Cryopreservation Outcomes in Potential $100B Tissue Engineering Market Enabled by BioLife Solutions CryoStor(TM) 3Improved Cryopreservation Outcomes in Potential $100B Tissue Engineering Market Enabled by BioLife Solutions CryoStor(TM) 4
(Date:8/18/2014)... ,Trustonic TEE technology ... devices  Trustonic, the leading provider of ... Fingerprint Cards AB (FPC) today announced a collaboration ... biometric authentication on connected devices. The ... FPC1021 and FPC1150) and sensor driver software that ...
(Date:8/18/2014)... new satellite image of Antarctica, and the imagery will ... into the effects of climate change. , Thanks to ... Dettwiler and Associates Ltd. (MDA), the prime contractor for ... (CCIN) at UWaterloo, the mosaic is free and fully ... , Using Synthetic Aperture Radar with multiple polarization modes ...
(Date:8/18/2014)... mass is made up of rangelands, which include grasslands ... alarming rate. Woody plants, such as trees and shrubs, ... loss of critical habitat and causing a drastic change ... specifically meat. , Researchers with Arizona State University,s ... this loss in both the United States and Argentina. ...
Breaking Biology News(10 mins):Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 2Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 4Waterloo makes public most complete Antarctic map for climate research 2Trees and shrubs invading critical grasslands, diminish cattle production 2Trees and shrubs invading critical grasslands, diminish cattle production 3
... sedatives have been the gold standard for treating newborns ... opiates themselves are superior to sedatives for treating infants ... pregnant. , Opiates appear to better "ameliorate the withdrawal, ... according to two new systematic reviews done by David ...
... For years, sedatives have been the gold standard for ... suggests that opiates themselves are superior to sedatives for ... methadone while pregnant. , Opiates appear to better "ameliorate ... of seizures," according to two new systematic reviews done ...
... Vast genetic resources ?"blue gold" on the international ... exploitation, warns a new report from the Japan-based ... , Increasingly recognized as important to humankind for ... resources are now more accessible and vulnerable than ...
Cached Biology News:Researchers discover new route to hemoglobin synthesis 2Opiates Better Than Sedatives For Treating Newborns In Withdrawal 2Clear rules needed to govern deep sea bioprospecting: UNU 2Clear rules needed to govern deep sea bioprospecting: UNU 3Clear rules needed to govern deep sea bioprospecting: UNU 4Clear rules needed to govern deep sea bioprospecting: UNU 5
Rabbit Anti-Human Janus Kinase 2 (JAK2 Polyclonal Antibody Family: Protein Kinase Sub-Family: TYK2/JAK Applications: ELISA, Western Blot...
MAb to HSV-2, gG-2 HSV-2 Glycoprotein G-2...
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
Biology Products: